Archer Investment Corporation’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-50
Closed -$10.8K 774
2021
Q1
$10.8K Hold
50
﹤0.01% 529
2020
Q4
$5.77K Hold
50
﹤0.01% 547
2020
Q3
$4.87K Hold
50
﹤0.01% 511
2020
Q2
$6.14K Hold
50
﹤0.01% 481
2020
Q1
$4K Sell
50
-100
-67% -$10.6K ﹤0.01% 505
2019
Q4
$16K Buy
150
+100
+200% +$11.2K 0.01% 407
2019
Q3
$6K Hold
50
﹤0.01% 387
2019
Q2
$9K Hold
50
0.01% 350
2019
Q1
$8K Hold
50
0.01% 356
2018
Q4
$5K Buy
+50
New +$6.56K ﹤0.01% 364

Other funds holding GWPH

Archer Investment Corporation's GWPH Position: Q2 2021 in Review

Archer Investment Corporation sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 50 shares — an estimated $10.8K sold.

Archer Investment Corporation first reported a position in GWPH in Q4 2018 and held it in 10 quarters. The position peaked at $16K in Q4 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Archer Investment Corporation reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Archer Investment Corporation sold 50 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $10.8K.
  • Archer Investment Corporation first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 10 quarters.
  • Archer Investment Corporation's GW Pharmaceuticals Plc American Depositary Shares position peaked at $16K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Archer Investment Corporation's 13F filing for Q2 2021, filed 5 Aug 2021.